logo

Latest Financial Updates

Read latest financial news update from our blog

Regeneron (REGN) Faces Setback with Phase 3 Trial Failure
Regeneron (REGN) Faces Setback with Phase 3 Trial Failure

Key Highlights: Regeneron (REGN, Financial) shares fell by nearly 18% after a Phase 3 tri...

Admin | Finance | 1 week ago

Merck (MRK) Antibody Drug Shows Promise in Lymphoma Trial
Merck (MRK) Antibody Drug Shows Promise in Lymphoma Trial

Merck (MRK, Financial) reveals promising results from its phase 2 study on diffuse large B...

Admin | Finance | 1 week ago

Disney Just Dropped the Ultimate Streaming Perk Bomb--And It's Not What You Think
Disney Just Dropped the Ultimate Streaming Perk Bomb--And It's Not What You Think

Walt Disney Co. (DIS, Financial) is rolling out a new wave of subscriber perks across its...

Admin | Finance | 1 week ago

NetApp (NTAP) Stock Rating Maintained by UBS at Neutral | NTAP Stock News
NetApp (NTAP) Stock Rating Maintained by UBS at Neutral | NTAP Stock News

On May 30, 2025, UBS analyst David Vogt announced a revised price target for NetApp Inc. (...

Admin | Finance | 1 week ago

Pfizer's (PFE) Braftovi Combo Boosts Survival in Cancer Trial
Pfizer's (PFE) Braftovi Combo Boosts Survival in Cancer Trial

Pfizer's late-stage trial shows significant advancements in Braftovi therapy for specific...

Admin | Finance | 1 week ago

Vanguard Total Bond Market ETF (BND) Declares Dividend
Vanguard Total Bond Market ETF (BND) Declares Dividend

Vanguard Total Bond Market ETF (BND, Financial) declares a dividend of $0.2403. 30-day SE...

Admin | Finance | 1 week ago

Strathcona (STHRF) Makes C$5.9B Bid for MEG Energy
Strathcona (STHRF) Makes C$5.9B Bid for MEG Energy

Strathcona Resources proposes to acquire MEG Energy in a C$5.9 billion deal. The offer co...

Admin | Finance | 1 week ago

Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting | PCSA Stock News
Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting | PCSA Stock News

Processa Pharmaceuticals (PCSA, Financial) will present three abstracts at the 2025 ASCO A...

Admin | Finance | 1 week ago

Join Our Newsletter

join our newsletter to receive update from us